ETF Managers Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$1.57M Sell
464,962
-323,651
-41% -$1.32M 0.05% 164
2022
Q4
$2.82M Buy
788,613
+104,102
+15% +$445K 0.13% 91
2022
Q3
$2.76M Sell
684,511
-52,814
-7% -$271K 0.09% 134
2022
Q2
$3.26M Sell
737,325
-88,094
-11% -$636K 0.09% 140
2022
Q1
$7.07M Buy
825,419
+203,329
+33% +$1.43M 0.14% 127
2021
Q4
$5.64M Sell
622,090
-39,023
-6% -$371K 0.11% 153
2021
Q3
$6.82M Buy
+661,113
New +$5.78M 0.13% 143

Other funds holding SRTA

ETF Managers Group's SRTA Position: Q1 2023 in Review

ETF Managers Group reduced its Strata Critical Medical Inc (SRTA) stake by 41% in Q1 2023, selling an estimated $1.32M and leaving 464,962 shares worth $1.57M. The position accounts for 0.05% of the portfolio, ranked #164.

ETF Managers Group first reported a position in SRTA in Q3 2021 and has held it in 7 quarters since. The position peaked at $7.07M in Q1 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • ETF Managers Group held 464,962 shares of Strata Critical Medical Inc worth $1.57M as of Q1 2023.
  • ETF Managers Group sold 323,651 Strata Critical Medical Inc shares in Q1 2023, an estimated $1.32M.
  • Strata Critical Medical Inc made up 0.05% of ETF Managers Group's portfolio in Q1 2023, its #164 holding.
  • ETF Managers Group first reported a position in Strata Critical Medical Inc in Q3 2021 and has held it in 7 quarters since.
  • ETF Managers Group's Strata Critical Medical Inc position peaked at $7.07M in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.